Cite

    Heinzlef, O. et al. (2002). Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. Journal of neurology, neurosurgery and psychiatry. 72 (5), pp. 647-649. [Online].